Skip to Main Content
our new site.
NLM Technical Bulletin
Full Text View
Drug-Drug Interaction Study Between Fenofibric Acid and Efavirenz
This study has been completed.
Study NCT00960570 Information provided by Mutual Pharmaceutical Company, Inc.
First Received on August 14, 2009. Last Updated on July 31, 2012
History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Interventions listed in this trial
Efavirenz 600 mg
Additional drug interventions recognized in this trial
More general drug interventions related to this trial
Lipid Regulating Agents
Molecular Mechanisms of Pharmacological Action
Nucleic Acid Synthesis Inhibitors
Reverse Transcriptase Inhibitors
Sponsors listed in this trial
Mutual Pharmaceutical Company, Inc.
Back to top of Main Content
Contact Help Desk
Lister Hill National Center for Biomedical Communications
U.S. National Library of Medicine
U.S. National Institutes of Health
U.S. Department of Health & Human Services
Freedom of Information Act
Links to all studies - primarily for crawlers